🇺🇸 FDA
Patent

US 6617309

Inhibitors of serine proteases, particularly hepatitis C virus NS3 protease

expired A61KA61K38/00A61P

Quick answer

US patent 6617309 (Inhibitors of serine proteases, particularly hepatitis C virus NS3 protease) held by Vertex Pharmaceuticals Incorporated expires Mon Sep 04 2023 00:00:00 GMT+0000 (Coordinated Universal Time). Status: expired.

Key facts

Applicant
Vertex Pharmaceuticals Incorporated
Grant date
Tue Sep 09 2003 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Sep 04 2023 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
32
CPC classes
A61K, A61K38/00, A61P, A61P1/16, A61P31/12